Enanta Pharmaceuticals
ENTA
ENTA
151 hedge funds and large institutions have $811M invested in Enanta Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 57 increasing their positions, 60 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
-21
Holders Change %
-12.21%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
9
Increased
57
Reduced
60
Closed
30
Calls
$58K
Puts
$3.57M
Net Calls
-$3.51M
Net Calls Change
-$1.37M
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
$57.1M |
| 2 |
State Street
Boston,
Massachusetts
|
$49.4M |
| 3 |
BlackRock
New York
|
$143M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
$7.53M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$75.8M |
Top Sellers
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
$4.67M |
| 2 |
Goldman Sachs
New York
|
$6.8M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$0 |
| 4 |
First Manhattan
New York
|
$10M |
| 5 |
Man Group
London,
United Kingdom
|
$7.46M |
